Loading…

Disease severity evaluation among dermatological out-patients: a comparison between the assessments of patients and physicians

Background  The assessment of a patient’s disease severity is an essential component in the formulation of treatment strategies. Objectives  To compare disease severity assessment by patients and by physicians, and to describe the possible discrepancies between them. Methods  For each patient, we ob...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology 2012-02, Vol.26 (2), p.213-218
Main Authors: Tabolli, S., Sampogna, F., Pagliarello, C., Paradisi, A., Spagnoli, A., Abeni, D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background  The assessment of a patient’s disease severity is an essential component in the formulation of treatment strategies. Objectives  To compare disease severity assessment by patients and by physicians, and to describe the possible discrepancies between them. Methods  For each patient, we obtained the Physician Global Assessment (PhGA) and the Patient Global Assessment (PtGA). Data were completed for 2.578 patients. Sixty‐one physicians participated in the study. We calculated the agreement between PtGA and PhGA scores using the weighted kappa statistics; a multinomial logistic regression was performed to assess the risk of disagreement considering both patient and physician variables. Results  Differences in the percentages of severity level, identified by patients and by physicians, were always statistically significant (P < 0.05). Overall, the weighted Cohen’s kappa was in the range of 0.09–0.34, depending on the diseases. Gender differences between patients and physicians did not influence the agreement. In the multinomial model female patients (OR = 1.38; 95% CI, 1.07–1.77), patients with higher educational levels (OR = 2.71; 95% CI, 2.12–3.46), and patients with impaired quality of life (OR = 1.56; 95% CI 1.23–1.97) had a higher risk to be underestimated for their disease severity by physicians, independently by physician gender and experience. Conclusions  Combining the subjective report with the objective severity assessment of the lesions, dermatologists may reach a better determination of how severity of disease is perceived by their patients and how they feel about the effectiveness of treatment. PtGA and PhGA might be considered in routine clinical assessments and not only for research activities.
ISSN:0926-9959
1468-3083
DOI:10.1111/j.1468-3083.2011.04038.x